Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 10 studies | 40% ± 18% | |
astrocyte | 8 studies | 26% ± 10% | |
retina horizontal cell | 6 studies | 37% ± 19% | |
glutamatergic neuron | 6 studies | 33% ± 11% | |
retinal rod cell | 4 studies | 35% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1753.52 | 2641 / 2642 | 100% | 35.08 | 703 / 705 |
adrenal gland | 100% | 892.40 | 258 / 258 | 90% | 13.76 | 206 / 230 |
uterus | 89% | 320.20 | 151 / 170 | 51% | 3.04 | 232 / 459 |
prostate | 90% | 345.34 | 221 / 245 | 28% | 0.47 | 139 / 502 |
ovary | 99% | 439.86 | 179 / 180 | 15% | 0.50 | 66 / 430 |
bladder | 90% | 422.57 | 19 / 21 | 18% | 1.06 | 90 / 504 |
tonsil | 0% | 0 | 0 / 0 | 67% | 5.02 | 30 / 45 |
breast | 27% | 56.79 | 122 / 459 | 34% | 1.51 | 377 / 1118 |
heart | 60% | 941.97 | 518 / 861 | 0% | 0 | 0 / 0 |
intestine | 41% | 90.54 | 393 / 966 | 11% | 0.47 | 59 / 527 |
esophagus | 32% | 75.83 | 464 / 1445 | 19% | 0.52 | 35 / 183 |
stomach | 27% | 103.55 | 96 / 359 | 10% | 0.38 | 28 / 286 |
lung | 8% | 15.96 | 46 / 578 | 25% | 1.05 | 290 / 1155 |
kidney | 30% | 59.65 | 27 / 89 | 3% | 0.04 | 23 / 901 |
skin | 6% | 13.17 | 113 / 1809 | 14% | 0.36 | 66 / 472 |
eye | 0% | 0 | 0 / 0 | 18% | 0.49 | 14 / 80 |
liver | 0% | 0 | 0 / 226 | 17% | 0.96 | 67 / 406 |
pancreas | 5% | 9.16 | 16 / 328 | 11% | 0.36 | 19 / 178 |
adipose | 12% | 22.08 | 143 / 1204 | 0% | 0 | 0 / 0 |
thymus | 6% | 9.83 | 38 / 653 | 5% | 0.12 | 29 / 605 |
blood vessel | 2% | 4.36 | 26 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 1.44 | 7 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.58 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0016020 | Cellular component | membrane |
GO_0005509 | Molecular function | calcium ion binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | RHBDL3 |
Protein name | Rhomboid like 3 Rhomboid-related protein 3 (EC 3.4.21.105) (Ventrhoid transmembrane protein) rhomboid protease (EC 3.4.21.105) |
Synonyms | VRHO RHBDL4 |
Description | FUNCTION: May be involved in regulated intramembrane proteolysis and the subsequent release of functional polypeptides from their membrane anchors. . |
Accessions | ENST00000536287.2 [P58872-2] P58872 ENST00000269051.9 [P58872-1] ENST00000431505.6 ENST00000578006.5 J3QQX4 ENST00000538145.5 [P58872-3] A4FU16 |